Registry for coronary artery disease and microvascular disease in cardiomyopathies
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
This study is trying to see how blockages in the heart's blood vessels affect the health and future of people with different types of heart muscle diseases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1600 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (La Tronche) |
| Trial ID | NCT03479580 on ClinicalTrials.gov |
What this trial studies
This observational registry evaluates the long-term prognostic value of macrovascular and microvascular coronary artery stenoses in patients with various types of cardiomyopathy, including ischemic, hypertrophic, dilated, and restrictive forms. The study utilizes advanced imaging techniques such as coronary angiography, cardiac magnetic resonance, and single-photon emission computed tomography to assess the incidence and prognosis of bystander coronary artery disease and microvascular disease. Conducted across five centers in France, the study aims to clarify the impact of these conditions on patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with ischemic, dilated, hypertrophic, or restrictive cardiomyopathy.
Not a fit: Patients who are pregnant, breastfeeding, or under legal protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of coronary artery disease's impact on cardiomyopathy prognosis, leading to improved patient management.
How similar studies have performed: While the study explores a novel approach to understanding the prognostic implications of coronary artery disease in cardiomyopathy, similar studies have shown promise in utilizing advanced imaging techniques for cardiovascular assessment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ischemic * Dilated * Hypertrophic * Restrictive cardiomyopathy. Exclusion Criteria: * Pregnant women * Breastfeeding women * Patients under legal protection
Where this trial is running
La Tronche
- University Hospital Grenoble — La Tronche, France (Recruiting)
Study contacts
- Principal investigator: Gilles BARONE-ROCHETTE, PI — University Hospital, Grenoble
- Study coordinator: Clémence CHARLON
- Email: ccharlon@chu-grenoble.fr
- Phone: 0033476766652
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.